Overview
Nadieh Drenth practices practicing medicine in Leiden, Netherlands.
Drenth is highly rated in 2 conditions, according to our data. Their clinical expertise encompasses Hereditary Cerebral Amyloid Angiopathy, Cerebral Amyloid Angiopathy, and Primary Amyloidosis.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nadieh Drenth
Is Nadieh Drenth a top-rated expert for Hereditary Cerebral Amyloid Angiopathy?
MediFind is an objective health platform that identifies experts based on real-world data. Nadieh Drenth is classified as an Advanced expert for Hereditary Cerebral Amyloid Angiopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nadieh Drenth participate in research or clinical trials?
Yes. Nadieh Drenth has published 10 articles and abstracts on conditions like Hereditary Cerebral Amyloid Angiopathy. You can view a list of Nadieh Drenth's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cerebral Amyloid Angiopathy
- Hereditary Cerebral Amyloid Angiopathy
- Experienced
- Primary AmyloidosisDrenth isExperienced. Learn about Primary Amyloidosis.